249 related articles for article (PubMed ID: 38164349)
1. The Regulatory Network of CREB3L1 and Its Roles in Physiological and Pathological Conditions.
Zhao Y; Yu Z; Song Y; Fan L; Lei T; He Y; Hu S
Int J Med Sci; 2024; 21(1):123-136. PubMed ID: 38164349
[TBL] [Abstract][Full Text] [Related]
2. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
[TBL] [Abstract][Full Text] [Related]
3. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
4. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
5. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
6. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract][Full Text] [Related]
7. A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children.
Zhang M; Yu Y; Guan X; Yao X; Jia C; Hong E; Guo Y; He L
Pathol Res Pract; 2022 Feb; 230():153754. PubMed ID: 34990868
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing epithelioid fibrosarcoma.
Patterson JW; Tchernev G; Chokoeva AA; Wick MR
Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
[TBL] [Abstract][Full Text] [Related]
9. Sclerosing Epithelioid Fibrosarcoma of the Kidney: First Reported Case in a Young Child.
Kurtz JL; Tan SY; Hazard FK
Pediatr Dev Pathol; 2021; 24(2):148-153. PubMed ID: 33470922
[TBL] [Abstract][Full Text] [Related]
10. Transcription factors activated through RIP (regulated intramembrane proteolysis) and RAT (regulated alternative translocation).
Ye J
J Biol Chem; 2020 Jul; 295(30):10271-10280. PubMed ID: 32487748
[TBL] [Abstract][Full Text] [Related]
11. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
[No Abstract] [Full Text] [Related]
12. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
[TBL] [Abstract][Full Text] [Related]
15. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
[TBL] [Abstract][Full Text] [Related]
16. Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion.
Argani P; Lewin JR; Edmonds P; Netto GJ; Prieto-Granada C; Zhang L; Jungbluth AA; Antonescu CR
Am J Surg Pathol; 2015 Mar; 39(3):365-73. PubMed ID: 25353281
[TBL] [Abstract][Full Text] [Related]
17. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
18. CREB3L1-mediated functional and structural adaptation of the secretory pathway in hormone-stimulated thyroid cells.
García IA; Torres Demichelis V; Viale DL; Di Giusto P; Ezhova Y; Polishchuk RS; Sampieri L; Martinez H; Sztul E; Alvarez C
J Cell Sci; 2017 Dec; 130(24):4155-4167. PubMed ID: 29093023
[TBL] [Abstract][Full Text] [Related]
19. Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.
Kosemehmetoglu K; Ardic F; Kilpatrick SE; Aydingoz U; Sumathi VP; Michal M
Virchows Arch; 2021 Apr; 478(4):767-777. PubMed ID: 33084978
[TBL] [Abstract][Full Text] [Related]
20. CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.
Liu LQ; Feng LF; Nan CR; Zhao ZM
Biosci Rep; 2018 May; 38(3):. PubMed ID: 29531016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
